Display options
Cite
Kotting P, Beicher K, McKeith IG, et al. Supporting clinical research in the NHS in England: the National Institute for Health Research Dementias and Neurodegenerative Diseases Research Network. Alzheimers Res Ther. 2012;4(4):23doi: 10.1186/alzrt126.
Kotting, P., Beicher, K., McKeith, I. G., & Rossor, M. N. (2012). Supporting clinical research in the NHS in England: the National Institute for Health Research Dementias and Neurodegenerative Diseases Research Network. Alzheimer's research & therapy, 4(4), 23. https://doi.org/10.1186/alzrt126
Kotting, Piers, et al. "Supporting clinical research in the NHS in England: the National Institute for Health Research Dementias and Neurodegenerative Diseases Research Network." Alzheimer's research & therapy vol. 4,4 (2012): 23. doi: https://doi.org/10.1186/alzrt126
Kotting P, Beicher K, McKeith IG, Rossor MN. Supporting clinical research in the NHS in England: the National Institute for Health Research Dementias and Neurodegenerative Diseases Research Network. Alzheimers Res Ther. 2012 Jul 06;4(4):23. doi: 10.1186/alzrt126. eCollection 2012. PMID: 22769969; PMCID: PMC3506937.
Copy Download .nbib Format: NLM
Share it on

Alzheimers Res Ther. 2012 Jul 06;4(4):23. doi: 10.1186/alzrt126. eCollection 2012.

Supporting clinical research in the NHS in England: the National Institute for Health Research Dementias and Neurodegenerative Diseases Research Network.

Alzheimer's research & therapy

Piers Kotting, Kris Beicher, Ian G McKeith, Martin N Rossor

Affiliations

  1. Department of Neurodegenerative Diseases, Institute of Neurology, University College London, London WC1N 3BG, UK.
  2. Newcastle University, Wolfson Research Center, Institute of Ageing & Health, Newcastle Upon Tyne NE4 5PL, UK.

PMID: 22769969 PMCID: PMC3506937 DOI: 10.1186/alzrt126

Abstract

Clinical research is best done when aligned with clinical care - that is, when the patient can be identified, recruited and, in many instances, researched in parallel with the delivery of clinical service. However, to achieve this effectively requires identification of the additional cost to the National Health Service clinical support services and the development of an appropriately skilled workforce. The National Institute for Health Research (NIHR) Cancer Research Network demonstrated the value of dedicated research support in terms of the number of patients recruited into clinical trials. Building on this model, the NIHR in England funded the Dementias and Neurodegenerative Diseases Research Network (DeNDRoN). DeNDRoN is now in its sixth year and has established a geographically widespread network of research support staff and research leadership managed by a central coordinating centre. Success can already be measured by a significant increase in the number of patients entering studies and the speed with which both commercial and noncommercial studies are completed. There are also early indications that the network will result in improved patient outcomes.

References

  1. Lancet Neurol. 2010 Oct;9(10):986-94 - PubMed
  2. Trials. 2010 May 13;11:53 - PubMed
  3. Eur J Neurol. 2012 Jan;19(1):149-54 - PubMed
  4. Ann Oncol. 2011 Nov;22 Suppl 7:vii2-vii4 - PubMed
  5. Int J Geriatr Psychiatry. 2011 Jul;26(7):767-9 - PubMed
  6. N Engl J Med. 2012 Mar 8;366(10):893-903 - PubMed
  7. Lancet. 2011 Jul 30;378(9789):403-11 - PubMed
  8. PLoS Med. 2010 Nov 09;7(11):e1000368 - PubMed
  9. Health Technol Assess. 2007 Nov;11(48):iii, ix-105 - PubMed
  10. J Clin Epidemiol. 2001 Mar;54(3):217-24 - PubMed

Publication Types